Cross-talk mechanisms in the development of insulin resistance of skeletalmuscle cells - Palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake
P. Storz et al., Cross-talk mechanisms in the development of insulin resistance of skeletalmuscle cells - Palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake, EUR J BIOCH, 266(1), 1999, pp. 17-25
Insulin resistance in skeletal muscle is one of the earliest symptoms assoc
iated with non-insulin-dependent diabetes mellitus (NTDDM). Tumour necrosis
factor (TNF) and nonesterified fatty acids have been proposed to be crucia
l factors in the development of the insulin-resistant state. We here show t
hat, although TNF downregulated insulin-induced insulin receptor (IR) and I
R substrate (IRS)-1 phosphorylation as well as phosphoinositide 3-kinase (P
I3-kinase) activity in pmi28 myotubes, this was, unlike in adipocytes, not
sufficient to affect insulin-induced glucose transport. Rather, TNF increas
ed membrane expression of GLUT1 and glucose transport in these muscle cells
. In contrast, the nonesterified fatty acid palmitate inhibited insulin-ind
uced signalling cascades not only at the level of IR and IRS-1 phosphorylat
ion, but also at the level protein kinase B (PKB/Akt), which is thought to
be directly involved in the insulin-induced translocation of GLUT4, and inh
ibited insulin-induced glucose uptake. Palmitate also abrogated TNF-depende
nt enhancement of basal glucose uptake, suggesting that palmitate has the c
apacity to render muscle cells resistant not only to insulin but also to TN
F with respect to glucose transport by GLUT4 and GLUT1, respectively. Our d
ata illustrate the complexity of the mechanisms governing insulin resistanc
e of skeletal muscle, questioning the role of TNF as a direct inhibitor of
glucose homoeostasis in this tissue and shedding new light on an as yet unr
ecognized multifunctional role for the predominant nonesterified fatty acid
palmitate in this process.